20 November 2008

Jourdan plc

("Jourdan" or the "Group")

AGM Statement

At today's Annual General meeting Jourdan's Chairman David Abell made the following statement.

"Sales and profits in the first four months of this financial year were in line with management expectations. The Westfield/Clinipak medical packaging business, now our principal trading business accounting for approximately 74% of sales in the first four months of trading, has achieved record sales and profits for the period. In contrast, the business of Nelsons and Corby are directly dependent on the high street and have suffered substantial reductions in sales and profits.

Working capital continues to be carefully managed but the Group is still vulnerable to both customer and supplier failures. Overall debt levels are running well below budget, indebtedness being currently 39% lower than at the same time last year. Current utilisation of the facility leaves a headroom of more than £2m compared with the facilities negotiated in June this year.

The Group is facing challenging times but we believe that our decision to focus Jourdan on the medical supplies sector is proving to be correct. Westfield/Clinipak exports nearly 50% of sales to some 80 countries and after the most massive sterling devaluation in my lifetime, this is an excellent place to be."

Enquiries:

Jourdan plc                                                                                  01476 403 456

David Abell, Chairman

Charles Stanley Securities                                                            020 7149 6000

Nominated Adviser

Russell Cook / Carl Holmes

RNS news service provided by Hemscott Group Limited.